# clm_56E2DDB08CBD

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_revenue  
value: 7,051,000,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2024-03-31  
published: 2023-11-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C8DA722C3664  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly revenue: 7,051,000,000 United States dollar", as of 2023-09-30 (until 2024-03-31). Claim clm_56E2DDB08CBD, https://asof.is/claim/clm_56E2DDB08CBD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209523000031/0000882095-23-000031-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2023, filed 2023-11-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209523000031/0000882095-23-000031-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-11-07)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_revenue | 6,599,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_56E2DDB08CBD](/claim/clm_56E2DDB08CBD.md) | [clm_1E9F69BD5141](/claim/clm_1E9F69BD5141.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.